Astragaloside IV, a saponin found in Astragalus membranaceus, was found beneficial against cerebral ischemia-reperfusion injury (138), motor deficits, and dopaminergic neuron degeneration in a MPTP PD mouse model (139) via NLRP3/Nrf2 pathway regulation. Here, NFE2L2 is linked to Parkinson disease.